S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Laser breakthrough could send stock soaring 2,467% (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Laser breakthrough could send stock soaring 2,467% (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Consumers are increasingly pushing back against price increases — and winning
Laser breakthrough could send stock soaring 2,467% (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Laser breakthrough could send stock soaring 2,467% (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Laser breakthrough could send stock soaring 2,467% (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Consumers are increasingly pushing back against price increases — and winning
Laser breakthrough could send stock soaring 2,467% (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Laser breakthrough could send stock soaring 2,467% (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Laser breakthrough could send stock soaring 2,467% (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Consumers are increasingly pushing back against price increases — and winning
Laser breakthrough could send stock soaring 2,467% (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
Laser breakthrough could send stock soaring 2,467% (Ad)
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Laser breakthrough could send stock soaring 2,467% (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Consumers are increasingly pushing back against price increases — and winning
Laser breakthrough could send stock soaring 2,467% (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists

Genenta Science (GNTA) Stock Forecast & Price Target

$3.90
-0.21 (-5.11%)
(As of 02/23/2024 ET)

Genenta Science Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Buy
Based on 1 Analyst Ratings

Analysts' Consensus Price Target

N/A

TypeCurrent Forecast
2/25/23 to 2/25/24
1 Month Ago
1/26/23 to 1/26/24
3 Months Ago
11/27/22 to 11/27/23
1 Year Ago
2/25/22 to 2/25/23
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/A$25.00$20.00$20.00
Predicted UpsideN/A298.09% Upside237.27% Upside237.27% Upside
Get Genenta Science Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GNTA and its competitors with MarketBeat's FREE daily newsletter.


GNTA Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GNTA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Genenta Science Stock vs. The Competition

TypeGenenta ScienceMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.68
2.48
Consensus RatingBuyModerate BuyHold
Predicted Upside1,899.82% Upside7.54% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/29/2023Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Raja
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:35 AM ET.












GNTA Price Target - Frequently Asked Questions

What is Genenta Science's consensus rating?

According to the issued ratings of 1 analysts in the last year, the consensus rating for Genenta Science stock is Buy based on the current 1 buy rating for GNTAthe . Learn more on GNTA's analyst rating history.

Do Wall Street analysts like Genenta Science more than its competitors?

Analysts like Genenta Science more than other Medical companies. The consensus rating for Genenta Science is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how GNTA compares to other companies.


Stock Ratings Reports and Tools

This page (NASDAQ:GNTA) was last updated on 2/25/2024 by MarketBeat.com Staff